Med. praxi. 2012;9(1):7-9

What causes dyspnoea in your patient?

MUDr.Hikmet Al-Hiti, Ph.D.
Klinika kardiologie IKEM, Praha

Dyspnoea is a common and very frequent symptom. It is second only to chest pain as the most common differential diagnostic consideration

in cardiology. The causes of dyspnoea are: pulmonary embolism; heart failure; congenital or acquired heart defects; bronchial, pulmonary

and pleural diseases; chronic anaemia; and pulmonary hypertension. Another very serious disease is pulmonary arterial hypertension.

Keywords: dyspnoea, pulmonary hypertension, pulmonary arterial hypertension

Published: February 13, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Al-Hiti H. What causes dyspnoea in your patient? Med. praxi. 2012;9(1):7-9.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rich S. Primary pulmonary hypúertension: Executive Summary from the World Symposium, 1988.
    2. Rubin LJ. Primary pulmonary hypertension. N Eng J Med 1997; 336: 111-117. Go to original source... Go to PubMed...
    3. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003; 361: 1533-1544. Go to original source... Go to PubMed...
    4. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Eng J Med 2004; 351: 1655-1665. Go to original source... Go to PubMed...
    5. The Task Force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J. 2009; 30: 2493-2537.
    6. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France Reults from a National Registry. Am J Respir Crit Care Med 2006; 173: 1023-1030. Go to original source... Go to PubMed...
    7. D´Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-349. Go to original source... Go to PubMed...
    8. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106: 1477-1482. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.